| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 2 | |
| #3 | Germany | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Measurement | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Analysing materials | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sahagun-Krause Heidi | 11 |
| #2 | Braxmeier Tobias | 11 |
| #3 | Seneci Pierfausto | 11 |
| #4 | Monse Barbara | 11 |
| #5 | Roder Hanno | 11 |
| #6 | Gordon Sandra | 11 |
| #7 | Thillaye Du Boullay Olivier | 8 |
| #8 | Casiraghi Laura | 6 |
| #9 | Klafki Hans | 5 |
| #10 | Ferrand Sandrine | 5 |
| Publication | Filing date | Title |
|---|---|---|
| DE10255343A1 | N, N-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors | |
| DE10161940A1 | N-carbacycle-monosubstituted indolocarbazoles as protein kinase inhibitors | |
| AU3923601A | Analytical method to evaluate animal models of neurofibrillary degeneration |